REAL-WORLD EFFECTIVENESS OF GLECAPREVIR/PIBRENTASVIR FOR HEPATITIS C VIRUS INFECTION
Glecaprevir and pibrentasvir (GLE/PIB) are direct-acting antiviral agents (DAAs) with pan-genotypic activity and a high barrier to resistance. We evaluated the effectiveness and safety of GLE/PIB in a large prospective registry HCV-infected individuals with/without coinfection by HIV and receiving DAAs for HCV infection. RUA-VHC (Madrid Registry of Use of DAA for HCV) is a prospective…